汤剂
肠道菌群
传统医学
药理学
医学
化学
免疫学
作者
Yanru Song,Yining Qiao,Shasha Gao,Miao Cao,Yujie Shan,Jingyu Mao,Xiaochun Chi,Liang Chang,Baoen Shan,Bingjie Huo
出处
期刊:Phytomedicine
[Elsevier BV]
日期:2025-08-05
卷期号:146: 157131-157131
被引量:2
标识
DOI:10.1016/j.phymed.2025.157131
摘要
These results suggest that HPXLD exerts significant therapeutic effects in GPL by rebalancing the gut microbiota, modulating tryptophan metabolism, and reducing inflammation. These findings not only validate the clinical potential of HPXLD in managing GPL but also underscore the significant contribution of the gut microbiota-metabolite-inflammation axis in the pathogenesis and treatment of precancerous gastric conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI